{"chunk_id": "medquad__chunk_33263", "source": "medquad", "text": "nigral degeneration is not responsive to levodopa. Dopamine and anticholinergics provide some benefit. Generally, treatment is reevaluated as the disorder progresses.\",NINDS,Striatonigral Degeneration\nWhat is the outlook for Striatonigral Degeneration ?,Striatonigral degeneration progresses slowly. Some patients have normal life expectancy.,NINDS,Striatonigral Degeneration\nwhat research (or clinical trials) is being done for Striatonigral Degeneration ?,The NINDS supports and conducts research o"}